Inari Medical, Inc. Share Price

Equities

NARI

US45332Y1091

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 17/06/2024 BST 5-day change 1st Jan Change
43.23 USD -4.57% Intraday chart for Inari Medical, Inc. -6.87% -33.41%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 599M 47.14B Sales 2025 * 705M 55.55B Capitalization 2.51B 198B
Net income 2024 * -49M -3.86B Net income 2025 * 8M 630M EV / Sales 2024 * 4.06 x
Net cash position 2024 * 80.82M 6.36B Net cash position 2025 * 115M 9.05B EV / Sales 2025 * 3.4 x
P/E ratio 2024 *
-47.3 x
P/E ratio 2025 *
305 x
Employees 1,300
Yield 2024 *
-
Yield 2025 *
-
Free-Float 90.6%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.57%
1 week-6.87%
Current month-13.54%
1 month-5.51%
3 months+6.35%
6 months-33.42%
Current year-33.41%
More quotes
1 week
42.81
Extreme 42.81
48.41
1 month
42.81
Extreme 42.81
52.10
Current year
36.73
Extreme 36.73
66.35
1 year
36.73
Extreme 36.73
71.85
3 years
36.73
Extreme 36.73
100.00
5 years
36.73
Extreme 36.73
127.42
10 years
36.73
Extreme 36.73
127.42
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 31/08/17
Director of Finance/CFO 65 28/02/19
Chief Tech/Sci/R&D Officer - 31/03/19
Members of the board TitleAgeSince
Director/Board Member 64 31/08/11
Chairman 70 31/08/11
Director/Board Member 57 31/10/19
More insiders
Date Price Change Volume
17/06/24 43.23 -4.57% 746,482
14/06/24 45.3 -1.31% 427,938
13/06/24 45.9 -2.09% 494,105
12/06/24 46.88 -1.45% 478,337
11/06/24 47.57 +2.48% 543,639

Delayed Quote Nasdaq, June 17, 2024 at 09:00 pm

More quotes
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral vasculature. The LimFlow system is indicated for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and are at risk of major amputation. It also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
43.23 USD
Average target price
64.4 USD
Spread / Average Target
+48.97%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW